$2.43 Billion is the total value of Perceptive Advisors's 214 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 98.9% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AEGR | Buy | AEGERION PHARMACEUTICALS INC | $399,310,000 | +76.4% | 4,656,682 | +30.3% | 16.44% | -28.0% |
SRPT | Buy | SAREPTA THERAPEUTICS INC | $226,641,000 | +118.9% | 23,044,138 | +746.6% | 9.33% | -10.6% |
ONXX | New | ONYX PHARMACEUTICALS INC | $138,902,000 | – | 1,113,888 | +100.0% | 5.72% | – |
ACRX | Buy | ACELRX PHARMACEUTICALS INC | $126,308,000 | +172.1% | 11,716,800 | +133.9% | 5.20% | +11.1% |
TSRO | Buy | TESARO INC | $117,278,000 | +289.1% | 3,027,288 | +228.9% | 4.83% | +58.9% |
CELG | Buy | CELGENE CORP | $112,402,000 | +898.2% | 729,238 | +657.6% | 4.63% | +307.7% |
GILD | Buy | GILEAD SCIENCES INC | $108,648,000 | +168.8% | 1,728,140 | +119.2% | 4.47% | +9.7% |
NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $96,688,000 | +42.2% | 8,541,408 | +68.1% | 3.98% | -41.9% |
RPRX | Buy | REPROS THERAPEUTICS INC | $79,420,000 | +2272.9% | 2,963,466 | +1533.4% | 3.27% | +867.2% |
VRTX | Buy | VERTEX PHARMACEUTICALS INC | $68,554,000 | +233.8% | 904,190 | +252.4% | 2.82% | +36.3% |
IBB | New | ISHARESput | $60,700,000 | – | 289,600 | +100.0% | 2.50% | – |
QCOR | Buy | QUESTCOR PHARMACEUTICALS INC | $43,656,000 | +2177.3% | 752,700 | +1684.2% | 1.80% | +831.1% |
EXAS | Buy | EXACT SCIENCES CORP | $41,260,000 | +79.8% | 3,496,628 | +112.0% | 1.70% | -26.6% |
MYL | New | MYLAN INC | $35,140,000 | – | 920,610 | +100.0% | 1.45% | – |
CI | Buy | CIGNA CORPORATION | $34,256,000 | +163023.8% | 445,696 | +153588.3% | 1.41% | +70400.0% |
NEPT | Buy | NEPTUNE TECHNOLOGIES BIORESO | $34,240,000 | +94.5% | 10,767,714 | +98.6% | 1.41% | -20.6% |
ACAD | Buy | ACADIA PHARMACEUTICALS INC | $33,548,000 | +154.4% | 1,221,230 | +68.1% | 1.38% | +3.8% |
SNTA | Buy | SYNTA PHARMACEUTICALS CORP | $30,052,000 | +123.6% | 4,762,472 | +76.8% | 1.24% | -8.7% |
HNT | New | HEALTH NET INC | $28,770,000 | – | 907,560 | +100.0% | 1.18% | – |
ARNA | New | ARENA PHARMACEUTICALS INCput | $26,962,000 | – | 5,116,200 | +100.0% | 1.11% | – |
PCRX | New | PACIRA PHARMACEUTICALS INC | $26,156,000 | – | 544,068 | +100.0% | 1.08% | – |
CSU | Buy | CAPITAL SR LIVING CORP | $25,976,000 | +21.9% | 1,228,178 | +37.8% | 1.07% | -50.2% |
F113PS | Buy | COVIDIEN PLC | $25,746,000 | +506.9% | 422,490 | +525.9% | 1.06% | +147.7% |
SNTS | Buy | SANTARUS INC | $24,046,000 | +82.8% | 1,064,486 | +70.3% | 0.99% | -25.4% |
CLVS | Buy | CLOVIS ONCOLOGY INC | $23,676,000 | +151.0% | 389,402 | +176.5% | 0.98% | +2.5% |
DYAX | Buy | DYAX CORP | $23,226,000 | +289.7% | 3,385,824 | +96.6% | 0.96% | +59.1% |
CTIC | New | CELL THERAPEUTICS INC | $22,676,000 | – | 13,989,346 | +100.0% | 0.93% | – |
ANAC | Buy | ANACOR PHARMACEUTICALS INC | $20,684,000 | +534.9% | 1,947,736 | +234.2% | 0.85% | +158.7% |
IWM | New | ISHARESput | $20,576,000 | – | 193,000 | +100.0% | 0.85% | – |
AMGN | New | AMGEN INC | $20,522,000 | – | 183,350 | +100.0% | 0.84% | – |
CHTP | Buy | CHELSEA THERAPEUTICS INTL LT | $20,440,000 | +90.8% | 6,836,730 | +46.8% | 0.84% | -22.1% |
SGMO | New | SANGAMO BIOSCIENCES INC | $20,246,000 | – | 1,930,000 | +100.0% | 0.83% | – |
WAG | New | WALGREEN CO | $20,214,000 | – | 375,740 | +100.0% | 0.83% | – |
P103PS | Buy | NPS PHARMACEUTICALS INC | $19,452,000 | +128.9% | 611,524 | +8.7% | 0.80% | -6.5% |
VNDA | New | VANDA PHARMACEUTICALS INC | $19,020,000 | – | 1,737,000 | +100.0% | 0.78% | – |
WCG | Buy | WELLCARE HEALTH PLANS INC | $18,422,000 | +87623.8% | 264,162 | +68513.5% | 0.76% | +37800.0% |
ISIS | New | ISIS PHARMACEUTICALS INC | $14,476,000 | – | 385,600 | +100.0% | 0.60% | – |
ECYT | Buy | ENDOCYTE INC | $11,162,000 | +1136.1% | 837,430 | +1117.1% | 0.46% | +405.5% |
AMRN | New | AMARIN CORP PLCput | $10,978,000 | – | 1,737,000 | +100.0% | 0.45% | – |
VNDA | New | VANDA PHARMACEUTICALS INCcall | $10,568,000 | – | 965,200 | +100.0% | 0.44% | – |
RPRX | New | REPROS THERAPEUTICS INCcall | $10,344,000 | – | 386,000 | +100.0% | 0.43% | – |
ITMN | Buy | INTERMUNE INC | $9,228,000 | +219.8% | 600,000 | +100.0% | 0.38% | +30.6% |
IMMU | Buy | IMMUNOMEDICS INC | $9,146,000 | +127.5% | 1,475,010 | +99.6% | 0.38% | -6.9% |
STML | Sell | STEMLINE THERAPEUTICS INC | $8,172,000 | -42.1% | 180,416 | -69.5% | 0.34% | -76.4% |
ARRY | Buy | ARRAY BIOPHARMA INC | $7,126,000 | +7997.7% | 1,145,740 | +5830.3% | 0.29% | +3155.6% |
CNDO | New | CORONADO BIOSCIENCES INCput | $7,038,000 | – | 1,003,800 | +100.0% | 0.29% | – |
ATHX | Buy | ATHERSYS INC | $7,052,000 | +22.1% | 4,300,234 | +23.6% | 0.29% | -50.2% |
ANIK | New | ANIKA THERAPEUTICS INC | $6,884,000 | – | 288,134 | +100.0% | 0.28% | – |
INFI | Buy | INFINITY PHARMACEUTICALS INC | $6,804,000 | +275.3% | 390,310 | +248.7% | 0.28% | +53.0% |
NBIX | New | NEUROCRINE BIOSCIENCES INCput | $6,554,000 | – | 579,000 | +100.0% | 0.27% | – |
PSDV | New | PSIVIDA CORP | $6,346,000 | – | 1,544,000 | +100.0% | 0.26% | – |
VSTM | New | VERASTEM INC | $6,002,000 | – | 482,130 | +100.0% | 0.25% | – |
MZOR | New | MAZOR ROBOTICS LTDsponsored ads | $5,986,000 | – | 354,156 | +100.0% | 0.25% | – |
MDVN | New | MEDIVATION INC | $5,784,000 | – | 96,500 | +100.0% | 0.24% | – |
NBS | New | NEOSTEM INC | $5,670,000 | – | 663,186 | +100.0% | 0.23% | – |
CSBR | Buy | CHAMPIONS ONCOLOGY INC RSTD | $5,452,000 | +174.1% | 3,116,488 | +72.3% | 0.22% | +11.4% |
VVUS | New | VIVUS INCput | $5,384,000 | – | 579,000 | +100.0% | 0.22% | – |
SPNC | Sell | SPECTRANETICS CORP | $5,178,000 | -17.9% | 308,158 | -8.8% | 0.21% | -66.5% |
ECYT | New | ENDOCYTE INCput | $5,146,000 | – | 386,000 | +100.0% | 0.21% | – |
DXCM | New | DEXCOM INC | $4,094,000 | – | 145,100 | +100.0% | 0.17% | – |
KERX | Buy | KERYX BIOPHARMACEUTICALS INC | $4,036,000 | +979.1% | 400,000 | +700.0% | 0.17% | +336.8% |
MGCD | Buy | MGC DIAGNOSTICS CORP | $3,820,000 | +162.2% | 348,898 | +100.0% | 0.16% | +6.8% |
ANTH | New | ANTHERA PHARMACEUTICALS INC | $3,468,000 | – | 862,912 | +100.0% | 0.14% | – |
CLDX | New | CELLDEX THERAPEUTICS INC NEWcall | $3,422,000 | – | 96,600 | +100.0% | 0.14% | – |
MNKD | New | MANNKIND CORP | $3,300,000 | – | 579,000 | +100.0% | 0.14% | – |
BCRX | New | BIOCRYST PHARMACEUTICALS | $2,774,000 | – | 381,176 | +100.0% | 0.11% | – |
MYGN | New | MYRIAD GENETICS INCcall | $2,740,000 | – | 116,600 | +100.0% | 0.11% | – |
MDGN | Buy | MEDGENICS INC | $2,340,000 | +310.5% | 300,000 | +100.0% | 0.10% | +68.4% |
TKMR | Buy | TEKMIRA PHARMACEUTICALS CORP | $2,224,000 | +78.8% | 318,618 | +18.0% | 0.09% | -26.4% |
VNDA | New | VANDA PHARMACEUTICALS INCput | $2,114,000 | – | 193,000 | +100.0% | 0.09% | – |
UPI | Buy | UROPLASTY INC | $2,012,000 | +225.0% | 607,978 | +103.3% | 0.08% | +33.9% |
ONTY | New | ONCOTHYREON INC | $1,988,000 | – | 965,000 | +100.0% | 0.08% | – |
AMRN | New | AMARIN CORP PLCcall | $1,830,000 | – | 289,600 | +100.0% | 0.08% | – |
PGNX | Buy | PROGENICS PHARMACEUTICALS IN | $1,698,000 | +24.1% | 338,136 | +10.3% | 0.07% | -49.3% |
TBIO | Buy | TRANSGENOMIC INC | $1,676,000 | +89.8% | 4,415,000 | +100.0% | 0.07% | -22.5% |
AVNR | New | AVANIR PHARMACEUTICALS INCput | $1,632,000 | – | 386,000 | +100.0% | 0.07% | – |
RGEN | New | REPLIGEN CORPput | $1,514,000 | – | 136,600 | +100.0% | 0.06% | – |
NSPH | New | NANOSPHERE INC | $1,358,000 | – | 679,000 | +100.0% | 0.06% | – |
VICL | New | VICAL INCcall | $1,000,000 | – | 800,000 | +100.0% | 0.04% | – |
ASTX | Sell | ASTEX PHARMACEUTICALS INC | $800,000 | -88.2% | 94,196 | -94.3% | 0.03% | -95.2% |
STEM | Buy | STEMCELLS INC | $778,000 | +103.7% | 463,200 | +100.0% | 0.03% | -17.9% |
HTWR | New | HEARTWARE INTL INC | $732,000 | – | 10,000 | +100.0% | 0.03% | – |
ACST | New | ACASTI PHARMA INC | $732,000 | – | 308,772 | +100.0% | 0.03% | – |
NAVB | New | NAVIDEA BIOPHARMACEUTICALS Iput | $618,000 | – | 233,000 | +100.0% | 0.02% | – |
XNPT | New | XENOPORT INC | $548,000 | – | 96,500 | +100.0% | 0.02% | – |
FURX | New | FURIEX PHARMACEUTICALS INC | $440,000 | – | 10,000 | +100.0% | 0.02% | – |
AZN | New | ASTRAZENECA PLCsponsored adr | $280,000 | – | 5,400 | +100.0% | 0.01% | – |
OCR | Buy | OMNICARE INC | $280,000 | +1300.0% | 5,050 | +1088.2% | 0.01% | +500.0% |
CNC | New | CENTENE CORP DEL | $302,000 | – | 4,710 | +100.0% | 0.01% | – |
CYH | New | COMMUNITY HEALTH SYS INC NEW | $284,000 | – | 6,830 | +100.0% | 0.01% | – |
LPNT | New | LIFEPOINT HOSPITALS INC | $280,000 | – | 5,990 | +100.0% | 0.01% | – |
HLS | Buy | HEALTHSOUTH CORP | $288,000 | +1340.0% | 8,380 | +1105.8% | 0.01% | +500.0% |
DVA | New | DAVITA HEALTHCARE PARTNERS I | $262,000 | – | 4,620 | +100.0% | 0.01% | – |
CVS | New | CVS CAREMARK CORPORATION | $262,000 | – | 4,600 | +100.0% | 0.01% | – |
HNGR | Buy | HANGER INC | $276,000 | +1280.0% | 8,160 | +1195.2% | 0.01% | +450.0% |
WOOF | Buy | VCA ANTECH INC | $258,000 | +1190.0% | 9,430 | +1109.0% | 0.01% | +450.0% |
AMSG | Buy | AMSURG CORP | $272,000 | +1260.0% | 6,830 | +1108.8% | 0.01% | +450.0% |
MD | Buy | MEDNAX INC | $276,000 | +1214.3% | 2,750 | +1122.2% | 0.01% | +450.0% |
ALR | Buy | ALERE INC | $270,000 | +1250.0% | 8,860 | +1007.5% | 0.01% | +450.0% |
AET | Sell | AETNA INC NEW | $266,000 | -96.3% | 4,140 | -96.3% | 0.01% | -98.5% |
MOH | Buy | MOLINA HEALTHCARE INC | $256,000 | +1180.0% | 7,180 | +1205.5% | 0.01% | +450.0% |
MGLN | Buy | MAGELLAN HEALTH SVCS INC | $274,000 | +1270.0% | 4,580 | +1154.8% | 0.01% | +450.0% |
KYTH | New | KYTHERA BIOPHARMACEUTICALS I | $252,000 | – | 5,530 | +100.0% | 0.01% | – |
ZLTQ | New | ZELTIQ AESTHETICS INC | $248,000 | – | 27,406 | +100.0% | 0.01% | – |
CUTR | Sell | CUTERA INC | $220,000 | -47.7% | 24,800 | -48.2% | 0.01% | -78.6% |
AXGN | New | AXOGEN INC | $40,000 | – | 9,000 | +100.0% | 0.00% | – |
CBMXW | Buy | COMBIMATRIX CORPORATION*w exp 05/01/201 | $4,000 | +300.0% | 10,000 | +100.0% | 0.00% | – |
ENDP | Exit | ENDO HEALTH SOLUTIONS INC | $0 | – | -530 | -100.0% | -0.00% | – |
DGX | Exit | QUEST DIAGNOSTICS INC | $0 | – | -325 | -100.0% | -0.00% | – |
MDAS | Exit | MEDASSETS INC | $0 | – | -1,150 | -100.0% | -0.00% | – |
V107SC | Exit | WELLPOINT INC | $0 | – | -255 | -100.0% | -0.00% | – |
UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -315 | -100.0% | -0.00% | – |
HRC | Exit | HILL ROM HLDGS INC | $0 | – | -590 | -100.0% | -0.00% | – |
HMA | Exit | HEALTH MGMT ASSOC INC NEWcl a | $0 | – | -1,265 | -100.0% | -0.00% | – |
NAVB | Exit | NAVIDEA BIOPHARMACEUTICALS Iput | $0 | – | -20,000 | -100.0% | -0.01% | – |
SNSS | Exit | SUNESIS PHARMACEUTICALS INC | $0 | – | -58,010 | -100.0% | -0.03% | – |
EPZM | Exit | EPIZYME INC | $0 | – | -18,000 | -100.0% | -0.05% | – |
LPDX | Exit | LIPOSCIENCE INC | $0 | – | -82,292 | -100.0% | -0.06% | – |
BMR | Exit | BIOMED REALTY TRUST INC | $0 | – | -50,000 | -100.0% | -0.10% | – |
CYCC | Exit | CYCLACEL PHARMACEUTICALS INC | $0 | – | -350,000 | -100.0% | -0.10% | – |
AMRN | Exit | AMARIN CORP PLCput | $0 | – | -193,000 | -100.0% | -0.11% | – |
VICL | Exit | VICAL INCcall | $0 | – | -400,000 | -100.0% | -0.13% | – |
VPHM | Exit | VIROPHARMA INC | $0 | – | -48,300 | -100.0% | -0.14% | – |
CEMP | Exit | CEMPRA INC | $0 | – | -200,000 | -100.0% | -0.16% | – |
SGEN | Exit | SEATTLE GENETICS INCput | $0 | – | -50,000 | -100.0% | -0.16% | – |
ANTH | Exit | ANTHERA PHARMACEUTICALS INC | $0 | – | -3,451,655 | -100.0% | -0.16% | – |
NBS | Exit | NEOSTEM INC | $0 | – | -3,315,938 | -100.0% | -0.19% | – |
BDSI | Exit | BIODELIVERY SCIENCES INTL IN | $0 | – | -477,600 | -100.0% | -0.20% | – |
QCOR | Exit | QUESTCOR PHARMACEUTICALS INCcall | $0 | – | -50,000 | -100.0% | -0.23% | – |
GILD | Exit | GILEAD SCIENCES INCput | $0 | – | -48,300 | -100.0% | -0.25% | – |
ARNA | Exit | ARENA PHARMACEUTICALS INCput | $0 | – | -393,200 | -100.0% | -0.30% | – |
NBIX | Exit | NEUROCRINE BIOSCIENCES INCput | $0 | – | -300,000 | -100.0% | -0.40% | – |
SQNM | Exit | SEQUENOM INC | $0 | – | -985,180 | -100.0% | -0.42% | – |
KMDA | Exit | KAMADA LTD | $0 | – | -394,860 | -100.0% | -0.44% | – |
CRIS | Exit | CURIS INC | $0 | – | -1,392,564 | -100.0% | -0.45% | – |
ELN | Exit | ELAN PLCadr | $0 | – | -483,000 | -100.0% | -0.69% | – |
OPTR | Exit | OPTIMER PHARMACEUTICALS INCput | $0 | – | -496,500 | -100.0% | -0.72% | – |
SHPG | Exit | SHIRE PLCsponsored adr | $0 | – | -80,800 | -100.0% | -0.78% | – |
SLXP | Exit | SALIX PHARMACEUTICALS INC | $0 | – | -148,250 | -100.0% | -0.99% | – |
SRPT | Exit | SAREPTA THERAPEUTICS INCcall | $0 | – | -275,000 | -100.0% | -1.06% | – |
HCA | Exit | HCA HOLDINGS INC | $0 | – | -308,560 | -100.0% | -1.12% | – |
SRPT | Exit | SAREPTA THERAPEUTICS INCput | $0 | – | -393,000 | -100.0% | -1.51% | – |
REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -139,310 | -100.0% | -3.16% | – |
IBB | Exit | ISHARES TRput | $0 | – | -269,400 | -100.0% | -4.72% | – |
BIIB | Exit | BIOGEN IDEC INC | $0 | – | -231,282 | -100.0% | -5.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13D | 2024-03-20 |
SC 13G | 2024-03-14 |
SC 13G | 2024-03-11 |
SC 13G/A | 2024-03-06 |
SC 13D/A | 2024-03-01 |
SC 13G | 2024-03-01 |
SC 13D/A | 2024-02-29 |
13F-HR/A | 2024-02-26 |
SC 13G/A | 2024-02-23 |
4 | 2024-02-21 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.